Pharmicell Co.,Ltd. Logo

Pharmicell Co.,Ltd.

Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.

005690 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로 874 (신사동, 쌍봉빌딩 7층), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology. The company is a pioneer in the field, having developed and commercialized Hearticellgram®-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its business is diversified across four main segments: stem cell therapeutics, including ongoing research for conditions like liver disease; a biochemical division that conducts oligonucleotide synthesis and produces nucleosides, mPEGs, and pharmaceutical intermediates; a stem cell banking business for adult and cord blood ('Twelve' brand); and a line of cosmetics derived from stem cell culture media ('By Pharmicell lab' brand).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Pharmicell Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 7.6 KB
2025-08-13 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.0 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 779.0 KB
2025-07-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.2 KB

Automate Your Workflow. Get a real-time feed of all Pharmicell Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmicell Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Tego Science, Inc. Logo
Develops cell therapies for skin regeneration, 3D models for testing, and provides CDMO services.
South Korea 191420
Teva Pharmaceutical Industries Ltd. Logo
A leader in affordable generic drugs and innovative specialty treatments for complex diseases.
Israel TEVA
THERAGEN ETEX CO.,LTD. Logo
A biotech firm offering gene analysis and developing personalized cancer drugs.
South Korea 066700
TheraVet SA Logo Belgium ALVET
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
A vertically integrated pharma company developing research-backed, EU-GMP medical cannabis products.
Israel TKUN
TiumBio Co., Ltd. Logo
Clinical-stage biopharma developing therapies for rare diseases, gynecology, and hemophilia.
South Korea 321550
TMS Co., Ltd Logo
Develops small molecule drugs from natural compounds for the global pharmaceutical market.
Japan 4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel TGTR
A pharmaceutical specialist in drugs for renal, skin, and allergic diseases.
Japan 4551

Talk to a Data Expert

Have a question? We'll get back to you promptly.